# Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk

> clinical trial · VERIFIED · 2026-07-09

Status: COMPLETED · Sponsor: Brigham and Women's Hospital · Condition: Type 2 Diabetes Mellitus

- Company: Brigham and Women's Hospital
- Sector: Type 2 Diabetes Mellitus
- Primary source: https://clinicaltrials.gov/study/NCT07619495

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.